This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vision-Sciences Selected As Preferred Vendor For Endoscopy Equipment By 21st Century Oncology

Orangeburg, NY, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Orangeburg, NY - December 19, 2013- Vision-Sciences, Inc. (NASDAQ: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, has entered into an agreement with 21 st Century Oncology, Inc., under which Vision-Sciences is 21 st Century's Preferred Vendor of Choice for endoscopy equipment used for evaluation and treatment procedures in multiple therapeutic and cancer care areas.  The equipment agreement includes several of the company's advanced fiberoptic and video based endoscopic imaging products, including flexible laryngoscopes, transnasal esophagoscopes, bronchoscopes, and cystoscopes, all of which are utilized in the diagnosing, treatment, and management of head and neck, esophageal, lung, and bladder cancers.

"We are pleased to have forged this multi-disciplinary agreement with 21 st Century Oncology, Inc.  This is another important validation of our 'always ready, always sterile' EndoSheath technology platform, which provides high-quality endoscopy while protecting patients against the hazards of inadequate endoscopic reprocessing," said Howard Zauberman, President and Chief Executive Officer of Vision-Sciences.  "We look forward to the continued growth of our franchise enabled by this agreement, which affords us the opportunity to outfit each of 21 st Century's 166 treatment centers in the U.S. and Latin America with state of the art imaging technology and the only sterile endoscopic solution in the market.

"In keeping with our commitment to delivering high quality care for patients, we have selected Vision-Sciences as our Preferred Vendor of Choice for endoscopy equipment," said Kathy Tolentino, Director Purchasing, 21st Century Oncology, Inc.  "Vision-Sciences' EndoSheath technology offers the only sterile, disposable option in flexible endoscopic treatment for the enhanced safety of patients.  This agreement provides us the most efficient and cost-effective manner to perform safe, efficacious endoscopic management."

About Vision-Sciences, Inc.

Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath ® technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety.  Information about Vision-Sciences' products is available at .

Vision-Sciences owns the trademarks Vision Sciences™ and Slide-On™ and the registered trademarks EndoSheath ®, EndoWipe ® and The Vision System ®.

About 21 st Century

21 st Century Oncology, Inc., which operates and manages radiation treatment centers primarily under the name 21st Century Oncology, offers a comprehensive range of radiation treatment alternatives and focuses on delivering academic-quality, cost-effective patient care in a personal and convenient setting.  The Company operates 166 treatment centers, including 133 centers located in 16 U.S. states and 33 centers in six Latin American countries. The Company holds market-leading positions in most of its domestic local markets and abroad.  21 st Century Oncology is headquartered in Fort Myers, Florida.


Keith Darragh                                                                                                                       Lisa Wilson

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs